| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,360 | 9,430 | 12:04 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Attendo Q4 2025 slides: EBITA surges 53%, sets ambitious 2028 EPS target | 2 | Investing.com | ||
| Do | Attendo steigert EBITDA um 53 % - Aktie reagiert mit Kurssprung | 2 | Investing.com Deutsch | ||
| Do | Attendo AB: Attendo's Year-End and fourth quarter report 2025: Strong fourth quarter and year - clear improvement in Scandinavia | 49 | GlobeNewswire (Europe) | Attendo ended 2025 with a strong fourth quarter and a positive trend in both our business areas. Higher occupancy, more accurate staffing planning and a continuing strong focus on quality combined to... ► Artikel lesen | |
| 28.10.25 | Attendo is changing its distribution channel for press releases | 3 | Cision News | ||
| 27.10.25 | Attendo AB: Attendo files claim against the city of Västerås after incorrect termination of home care contract | 203 | GlobeNewswire (Europe) | Attendo's view is that the City of Västerås had no basis for the termination of the home care agreement that occurred earlier this year. Attendo has also been informed that the preliminary investigations... ► Artikel lesen | |
| ATTENDO Aktie jetzt für 0€ handeln | |||||
| 27.10.25 | Attendo AB: Attendo divests its child welfare and family care operations in Finland | 271 | GlobeNewswire (Europe) | Attendo and Validia have signed an agreement whereby Attendo will divest its childcare and family care operations in Finland, with Validia as the new owner. The transaction is expected to close in the... ► Artikel lesen | |
| 27.10.25 | Ambea, through its Finnish business area Validia, has entered into an agreement to acquire Attendo's child welfare and family care services in Finland | 1 | Cision News | ||
| 24.10.25 | Attendo AB: Attendo's interim report for July-September 2025: The strongest quarter to date, driven by the development in Finland | 143 | GlobeNewswire (Europe) | Developments continued to be positive during the third quarter of the year, primarily driven by the Finnish operations and increased occupancy in nursing homes in both Finland and Scandinavia. The strong... ► Artikel lesen | |
| 23.09.25 | ATTENDO: Repurchases of shares during week 38, 2025 | 1 | Cision News | ||
| 18.09.25 | Attendo terminates Home Care contracts in Katrineholm and Nyköping | 2 | Cision News | ||
| 16.09.25 | ATTENDO: Repurchases of shares during week 37, 2025 | 1 | Cision News | ||
| 15.09.25 | Attendo has completed the acquisition of Främja AB - grows within LSS under the Unika brand | 1 | Cision News | ||
| 09.09.25 | ATTENDO: Repurchases of shares during week 36, 2025 | 3 | Cision News | ||
| 02.09.25 | ATTENDO: Repurchases of shares during week 35, 2025 | 1 | Cision News | ||
| 26.08.25 | ATTENDO: Repurchases of shares during week 34, 2025 | 2 | Cision News | ||
| 19.08.25 | ATTENDO: Repurchases of shares during week 33, 2025 | 1 | Cision News | ||
| 12.08.25 | ATTENDO: Repurchases of shares during week 32, 2025 | 1 | Cision News | ||
| 18.07.25 | Attendo AB: Attendo's Report For April-june 2025: Strong Quarter With Continued Earnings Growth | 413 | GlobeNewswire (Europe) | Attendo reports continued earnings growth, strong cash flow and high satisfaction among customers and employees in the second quarter of 2025. The results are mainly driven by the Finnish operations... ► Artikel lesen | |
| 08.05.25 | Dividendenbekanntmachungen (08.05.2025) | 12.829 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDNODE GROUP AB SE0017885767 1,15 SEK 0,1052 EUR AG BARR PLC GB00B6XZKY75 0,1376 GBP 0,1617 EUR ALANTRA PARTNERS SA ES0126501131 - 0... ► Artikel lesen | |
| 07.05.25 | Attendo AB: Attendo's First Quarter Report 2025: Strong Start To The Year Driven By Finland | 276 | GlobeNewswire (Europe) | Attendo reports a strong start to the year 2025, both operationally and financially. In Finland, the operating result continued to improve due to a fast adaptation to new staffing requirements, leading... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | Fresenius: 2026 setzt sich das Wachstum fort | Am 25. Februar wird Fresenius Zahlen zum vierten Quartal publizieren. Die Analysten der DZ Bank rechnen mit einer soliden Entwicklung. Wachstumsinvestitionen bei Kabi dürften sich bei den Margen bemerkbar... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen | |
| UNITEDHEALTH | 232,15 | -0,77 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| RXSIGHT | 8,390 | +7,29 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer |
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |